Please use this identifier to cite or link to this item: http://www.repositorio.ufop.br/handle/123456789/8511
Title: Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(ii)-based compounds with antitumoral activity.
Authors: Camargo, Mariana Santoro de
Silva, Monize Martins da
Correa, Rodrigo de Souza
Vieira, Sara Dourado
Castelli, Silvia
D’Anessa, Ilda
Grandis, Rone De
Varanda, Eliana Aparecida
Deflon, Victor Marcelo
Desideri, Alessandro
Batista, Alzir Azevedo
Issue Date: 2016
Citation: CAMARGO, M. S. et al. Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(ii)-based compounds with antitumoral activity. Metallomics , v. 8, p. 179-192, 2016. Disponível em: <http://pubs.rsc.org/en/content/articlepdf/2016/mt/c5mt00227c>. Acesso em: 05 ago. 2017.
Abstract: Herein we synthesized two new ruthenium(II) compounds [Ru(pySH)(bipy)(dppb)]PF6 (1) and [Ru(HSpym)(bipy)- (dppb)]PF6 (2) that are analogs to an antitumor agent recently described, [Ru(SpymMe2)(bipy)(dppb)]PF6 (3), where [(Spy) = 2-mercaptopyridine anion; (Spym) = 2-mercaptopyrimidine anion and (SpymMe2) = 4,6-dimethyl-2-mercaptopyrimidine anion]. In vitro cell culture experiments revealed significant antiproliferative activity for 1–3 against HepG2 and MDA-MB-231 tumor cells, higher than the standard anticancer drugs doxorubicin and cisplatin. No mutagenicity is detected when compounds are evaluated by cytokinesis-blocked micronucleus cytome and Ames test in the presence and absence of S9 metabolic activation from rat liver. Interaction studies show that compounds 1–3 can bind to DNA through electrostatic interactions and to albumin through hydrophobic interactions. The three compounds are able to inhibit the DNA supercoiled relaxation mediated by human topoisomerase IB (Top1). Compound 3 is the most efficient Top1 inhibitor and the inhibitory effect is enhanced upon pre-incubation with the enzyme. Analysis of different steps of Top1 catalytic cycle indicates that 3 inhibits the cleavage reaction impeding the binding of the enzyme to DNA and slows down the religation reaction. Molecular docking shows that 3 preferentially binds closer to the residues of the active site when Top1 is free and lies on the DNA groove downstream of the cleavage site in the Top1–DNA complex. Thus, 3 can be considered in further studies for a possible use as an anticancer agent.
URI: http://www.repositorio.ufop.br/handle/123456789/8511
metadata.dc.identifier.uri2: http://pubs.rsc.org/en/content/articlepdf/2016/mt/c5mt00227c
ISSN: 1756591X
Appears in Collections:DEQUI - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_InhibitionHumanDNA.pdf2,54 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.